BDRX
BIODEXA PH SP ADR (BDRX)
NASDAQ
$3.57+$0.06 (+1.86%)
Price as of Jun 03, 2026 6:29 PM EDT
  • $2.6M
    Market Cap
  • -93.97%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
381,000
-45.49%
699,000
+20.93%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
-100.00%
381,000
-45.49%
699,000
+20.93%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.0M
-27.15%
-5.4M
+33.69%
-4.1M
-20.43%
-5.1M
+9.82%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
-8.6M
-6.02%
-9.2M
+14.79%
-8.0M
-10.28%
-8.9M
+27.64%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
152,000
+390.32%
31,000
+121.43%
14,000
-36.36%
22,000
-8.33%
Income before Taxes
N/A
N/A
N/A
N/A
-7.1M
-7.54%
-7.7M
+40.22%
Income Taxes
-105,000
-58.00%
-250,000
-38.42%
-406,000
-51.20%
-832,000
-228.79%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-7.1M
-7.54%
-7.7M
+40.22%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-7.1M
-7.54%
-7.7M
+40.22%
Basic EPS and Net Income
-0.0001
-90.00%
-0.001
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.0001
-90.00%
-0.001
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
54.9B
+1,007.68%
5.0B
+1,468.08%
315.8M
+219.57%
98.8M
+22.71%
Diluted Weighted Average Shares
54.9B
+1,007.68%
5.0B
+1,468.08%
315.8M
+219.57%
98.8M
+22.71%
Balance Sheet
Cash and Cash Equivalents
8.5M
+411.02%
1.7M
-72.03%
6.0M
+110.54%
2.8M
-71.80%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.5M
+411.02%
1.7M
-72.03%
6.0M
+110.54%
2.8M
-71.80%
Total Current Assets
12.4M
+41.24%
8.8M
+25.32%
7.0M
+49.96%
4.7M
-60.14%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
324,000
-43.26%
571,000
-31.29%
831,000
-27.86%
Total Long-Term Assets
5.7M
-3.92%
6.0M
+69.99%
3.5M
+319.59%
837,000
-27.34%
Total Assets
18.2M
+23.00%
14.8M
+40.20%
10.5M
+90.81%
5.5M
-57.21%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.1M
+21.75%
5.0M
-9.61%
5.6M
+193.11%
1.9M
+3.20%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
645,000
-54.71%
1.4M
+382.71%
295,000
-36.29%
463,000
-25.32%
Total Liabilities
6.8M
+4.89%
6.5M
+10.13%
5.9M
+148.16%
2.4M
-3.98%
Retained Earnings
-155.8M
+3.58%
-150.4M
+3.91%
-144.8M
+6.97%
-135.3M
+5.89%
Total Stockholders Equity
N/A
N/A
N/A
N/A
4.7M
+47.94%
3.2M
-69.75%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
494,548
-99.99%
Cash Flow
Cash from Operating Activities
-5.6M
-54.40%
-12.3M
+79.62%
-6.8M
-3.15%
-7.0M
+17.31%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-583,000
-2.51%
-598,000
+125.66%
-265,000
+20.45%
-220,000
-20.86%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
13.0M
+52.38%
8.6M
-16.32%
10.2M
+21,657.45%
47,000
-99.47%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-2,103.41%
+64.61%
-1,277.83%
+5.54%
Return on Assets
N/A
N/A
N/A
N/A
-88.12%
+6.11%
-83.05%
+72.86%
Return on Equity
N/A
N/A
N/A
N/A
-180.59%
+60.56%
-112.47%
+76.85%
Revenue Growth
N/A
N/A
N/A
N/A
-45.49%
-317.32%
20.93%
-69.44%
Current Ratio
2.03
+16.00%
1.75
+38.64%
1.26
-48.84%
2.47
-61.38%
Cash Ratio
1.39
+319.78%
0.33
-69.06%
1.07
-28.17%
1.49
-72.68%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow